JP Morgan Chase’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-65,000
Closed -$1.32M 7416
2024
Q3
$1.32M Hold
65,000
﹤0.01% 4300
2024
Q2
$1.47M Hold
65,000
﹤0.01% 4006
2024
Q1
$1.71M Buy
65,000
+15,000
+30% +$427K ﹤0.01% 3964
2023
Q4
$1.58M Hold
50,000
﹤0.01% 4010
2023
Q3
$1.4M Buy
+50,000
New +$1.72M ﹤0.01% 3832
2021
Q4
Sell
-200,000
Closed -$5.81M 6670
2021
Q3
$5.81M Buy
+200,000
New +$6.47M ﹤0.01% 2913
2019
Q4
Sell
-10,000
Closed -$149K 5618
2019
Q3
$149K Sell
10,000
-410,000
-98% -$6.67M ﹤0.01% 4749
2019
Q2
$10.5M Buy
+420,000
New +$12.4M ﹤0.01% 2070
2016
Q3
Sell
-61,000
Closed -$503K 4556
2016
Q2
$503K Buy
+61,000
New +$543K ﹤0.01% 3431
2016
Q1
Sell
-42,400
Closed -$227K 4668
2015
Q4
$227K Buy
42,400
+7,900
+23% +$50.5K ﹤0.01% 3621
2015
Q3
$223K Buy
+34,500
New +$361K ﹤0.01% 3657

Other funds holding CC

JP Morgan Chase's CC Position: Q1 2026 in Review

JP Morgan Chase reduced its Chemours (CC) stake by 3.7% in Q1 2026, selling an estimated $2.53M and leaving 3,800,873 shares worth $80.6M. The position accounts for 0.01% of the portfolio, ranked #1098.

JP Morgan Chase first reported a position in CC in Q3 2015 and has held it in 43 quarters since. The position peaked at $129M in Q2 2023. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • JP Morgan Chase held 3,800,873 shares of Chemours worth $80.6M as of Q1 2026.
  • JP Morgan Chase sold 145,334 Chemours shares in Q1 2026, an estimated $2.53M.
  • Chemours made up 0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1098 holding.
  • JP Morgan Chase first reported a position in Chemours in Q3 2015 and has held it in 43 quarters since.
  • JP Morgan Chase's Chemours position peaked at $129M in Q2 2023.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.